|
Cancer Questions on the National Health Interview Survey
|
APC12017-001
|
$1,300,000
|
N/A
|
National Center for Health Statistics
|
|
Research Management and Support - Total
|
RMS2012 [E]
|
$374,919,382
|
N/A
|
(NCI)
|
|
Linxian nutrition intervention trials - etiologic studies
|
ZIA CP000112-10339
|
$129,538
|
Abnet, Christian
|
DCEG (NCI)
|
|
Using Email to Enhance Counseling Services at NCI's Smoking Cessation Quitline
|
5K07CA124579-05
|
$134,528
|
ABROMS, LORIEN
|
GEORGE WASHINGTON UNIVERSITY
|
|
Validation of a risk model for stage I lung adenocarcinoma
|
1R21CA164568-01A1
|
$241,931
|
Adusumilli, Prasad
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Participation in the Eastern Cooperative Oncology Group
|
5U10CA107868-09
|
$216,434
|
AISNER, JOSEPH
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
|
Prospective study of farmers and their families (Agricultural health study)
|
ZIA CP010119-02020
|
$1,451,134
|
Alavanja, Michael
|
DCEG (NCI)
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,176,890
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Immuno/Immuno-Gene Therapies for Thoracic Malignancies
|
2P01CA066726-15A1
|
$1,182,811
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S1
|
$75,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S2
|
$143,846
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-34
|
$3,953,813
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Southeast Michigan Community Network Program
|
5U54CA153606-03
|
$780,541
|
ALBRECHT, TERRANCE
|
WAYNE STATE UNIVERSITY
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144-07130
|
$1,264,778
|
Alter, Blanche
|
DCEG (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-43S1
|
$127,557
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-43
|
$2,516,654
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Rational Design and Clinical Development of Shepherdin: A Novel Anti-Cancer Agent
|
5R01CA118005-05
|
$350,890
|
Altieri, Dario
|
WISTAR INSTITUTE
|
|
Lung cancer heterogeneity and its impact on drug resistance.
|
5R01CA133253-03
|
$453,829
|
ALTSCHULER, STEVEN
|
UNIV OF TX SW MED CTR-DALLAS
|
|
Targeting EphA2 in Tyrosine Kinase Inhibitor Resistant Lung Cancer
|
1F31CA167878-01
|
$26,849
|
Amato, Katherine
|
VANDERBILT UNIVERSITY MED CTR
|
|
Convergence of CREB and MYC Pathways in Oncogenesis.
|
1K99CA157954-01A1
|
$147,150
|
Amelio, Antonio
|
SCRIPPS FLORIDA
|
|
COMBINATORIAL-DESIGNED NANO-PLATFORMS TO OVERCOME TUMOR DRUG RESISTANCE
|
5U01CA151452-03
|
$413,032
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
Transdisciplinary Research in Cancer of the Lung (TRICL)
|
7U19CA148127-03
|
$2,636,071
|
AMOS, CHRISTOPHER
|
DARTMOUTH COLLEGE
|
|
Molecular Mechanisms of EGF Signaling & Iressa/Tarceva Inhibition in NSCLC
|
5R01CA127580-05
|
$314,248
|
ANDERSON, KAREN
|
YALE UNIVERSITY
|
|
The University of Kentucky Cancer Nanotechnology Training Center (UK CNTC)
|
5R25CA153954-03
|
$321,854
|
Anderson, Bradley
|
UNIVERSITY OF KENTUCKY
|
|
Extension of Radiotherapy Research
|
5R01CA168485-02
|
$291,567
|
ANG, K
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Development of Immunotherapeutic Strategies in the Treatment of Lung Cancer
|
5K24CA128953-05
|
$171,205
|
ANTONIA, SCOTT
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Translating Research into Systemic Interventions for Tobacco Cessation
|
5K07CA140236-02
|
$166,320
|
Apollonio, Dorothy
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
Impact of Mortality Concerns on Cancer Risk Behavior
|
5R01CA096581-09
|
$239,827
|
ARNDT, JAMIE
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
|
OTHER FUNCTIONS - SIMULATION MODELING
|
N02CA120468-000
|
$24,904
|
ARNOLD, HEATHER
|
DARTMOUTH COLLEGE
|
|
SOUTHEAST CANCER CONTROL COSORTIUM, INC
|
3U10CA045808-18S1
|
$323,511
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Southeast Cancer Control Consortium, Inc
|
5U10CA045808-26
|
$1,476,477
|
Atkins, James
|
SOUTHEAST CANCER CONTROL CONSORTIUM
|
|
Telomeres, telomerase and chemotherapy: Bench to bedside
|
5R01CA077091-09
|
$333,500
|
Au, Jessie
|
OPTIMUM THERAPEUTICS, LLC
|
|
The Protective Effects of Physical Activity on AdolescentSmoking Progression
|
5R01CA126958-05
|
$449,361
|
AUDRAIN-MCGOVERN, JANET
|
UNIVERSITY OF PENNSYLVANIA
|
|
New Cancer Vaccine Technology Based on DRibbles Produced by Tumor Cells
|
5R44CA121612-05
|
$648,309
|
Aung, Sandra
|
UBIVAC, LLC
|
|
Role of Mitochondrial Respiratory Stress Signaling in Cancer Progression
|
5R01CA022762-32
|
$330,150
|
AVADHANI, NARAYAN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Eastern Cooperative Oncology Group Studies
|
5U10CA014548-38
|
$354,850
|
AVERBOOK, BRUCE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Using FAP to Selectively Target Epithelial Cancers
|
1R01CA163930-01A1
|
$372,632
|
BACHOVCHIN, WILLIAM
|
TUFTS UNIVERSITY BOSTON
|
|
Optical Nanoscale Analysis of Buccal Cells: Transforming Lung Cancer Screening
|
5R01CA155284-02
|
$590,916
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Therapeutic miRNAs in combination with conventional chemotherapy
|
1R43CA165450-01A1
|
$299,999
|
Bader, Andreas
|
MIRNA THERAPEUTICS, INC.
|
|
San Juan Minority - Based Community Clinical Oncology Program
|
5U10CA052667-22
|
$536,603
|
BAEZ, LUIS
|
SAN JUAN HEALTH DEPARTMENT
|
|
SWOG Community Clinical Oncology Program Research Base
|
2U10CA037429-28
|
$1,371,233
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group Treatment Grant
|
3U10CA032102-33S1
|
$196,749
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group Biorepository
|
3U24CA114748-07S1
|
$697,714
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Psycho-sociocultural factors influencing cancer pain management in elderly adults
|
5K01CA131722-04
|
$140,069
|
Baker, Tamara
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Training in Translational Tobacco Science
|
5K05CA139871-05
|
$170,073
|
Baker, Timothy
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Southwest Oncology Group Treatment Grant
|
5U10CA032102-33
|
$8,923,498
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Southwest Oncology Group Biorepository
|
5U24CA114748-07
|
$1,125,491
|
BAKER, LAURENCE
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Ras-Induced Lung Cancer: Key Roles for IKK and NF-kappaB
|
5R01CA073756-13
|
$252,369
|
BALDWIN, ALBERT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
The role of the Kras4A isoform in epithelial carcinogenesis
|
2R01CA111834-06A1
|
$269,732
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
|
A Systems Genetics Analysis of Cancer Risk, Progression and Therapeutic Response
|
5U01CA084244-14
|
$759,738
|
BALMAIN, ALLAN
|
UNIVERSITY OF CALIFORNIA-SAN FRANCISCO
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|